General Ophthalmology

17-32 of 391

• 

  RestartResume

  VBS Fellows’ Foray 2026: Through the Looking Glass—Real-World Vitreoretinal Surgical Cases

  RestartResume

  VBS Fellows’ Foray 2026: Through the Looking Glass—Real-World Vitreoretinal Surgical Cases

  CME/CE

  VBS Fellows’ Foray 2026: Through the Looking Glass—Real-World Vitreoretinal Surgical Cases

  Yewlin E. Chee, MD; Camila Ventura MD, PhD

  1.50 credits

  • 

    

    Yewlin E. Chee, MD

  • 

    

    Camila Ventura MD, PhD

  • 

    

    Edward Wood, MD

  • 

    

    Tony Capone Jr, MD

  • 

    

    Katherine E. Talcott, MD

  • 

    

    Nassim Abreu, MD

  1.50 credits

• 

  RestartResume

  Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies

  RestartResume

  Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies

  CME/CE Broadcast Replay

  Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies

  Deepak Sambhara, MD

  1.00 credit

  • 

    

    Deepak Sambhara, MD

  1.00 credit

• 

  RestartResume

  It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  RestartResume

  It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  CME/CE

  It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  David Eichenbaum, MD

  0.25 credits

  • 

    

    David Eichenbaum, MD

  0.25 credits

• 

  RestartResume

  A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  RestartResume

  A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  CME/CE

  A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  Esther Lee Kim, MD

  0.25 credits

  • 

    

    Esther Lee Kim, MD

  0.25 credits

• 

  RestartResume

  Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  RestartResume

  Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  CME/CE

  Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  Deepak Sambhara, MD

  0.25 credits

  • 

    

    Deepak Sambhara, MD

  0.25 credits

• 

  RestartResume

  Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  RestartResume

  Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  CME/CE

  Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  David Chin Yee, MD, FASRS

  0.25 credits

  • 

    

    David Chin Yee, MD, FASRS

  0.25 credits

• 

  RestartResume

  Phaco Reloaded: Level Up Your Cataract Game

  RestartResume

  Phaco Reloaded: Level Up Your Cataract Game

  CME/CE

  Phaco Reloaded: Level Up Your Cataract Game

  Eric D. Donnenfeld, MD; Marjan Farid, MD

  1.00 credit

  • 

    

    Eric D. Donnenfeld, MD

  • 

    

    Marjan Farid, MD

  • 

    

    Jason J. Jones, MD

  • 

    

    Eva I. Liang, MD, FACS

  • 

    

    Carlton Yuen, MD

  1.00 credit

• 

  RestartResume

  Sustaining Visual Benefits of Photobiomodulation in Dry Age-Related Macular Degeneration

  RestartResume

  Sustaining Visual Benefits of Photobiomodulation in Dry Age-Related Macular Degeneration

  MinuteCE®

  Sustaining Visual Benefits of Photobiomodulation in Dry Age-Related Macular Degeneration

  Marion Munk, MD, Ph.D; David Boyer, MD

  1.00 program credit

  • 

    

    Marion Munk, MD, Ph.D

  • 

    

    David Boyer, MD

  1.00 program credit

• 

  RestartResume

  Clinical and Safety Outcomes from the LIGHTSITE III Trial

  RestartResume

  Clinical and Safety Outcomes from the LIGHTSITE III Trial

  MinuteCE®

  Clinical and Safety Outcomes from the LIGHTSITE III Trial

  David Boyer, MD; Diana V. Do, MD

  1.00 program credit

  • 

    

    David Boyer, MD

  • 

    

    Diana V. Do, MD

  1.00 program credit

• 

  RestartResume

  Best Practices for Optimized Photobiomodulation Treatment Effect: Candidate Selection

  RestartResume

  Best Practices for Optimized Photobiomodulation Treatment Effect: Candidate Selection

  MinuteCE®

  Best Practices for Optimized Photobiomodulation Treatment Effect: Candidate Selection

  Marion Munk, MD, Ph.D; Diana V. Do, MD

  1.00 program credit

  • 

    

    Marion Munk, MD, Ph.D

  • 

    

    Diana V. Do, MD

  1.00 program credit

• 

  RestartResume

  Anatomical Outcomes from the LIGHTSITE III Trial

  RestartResume

  Anatomical Outcomes from the LIGHTSITE III Trial

  MinuteCE®

  Anatomical Outcomes from the LIGHTSITE III Trial

  Diana V. Do, MD; David Boyer, MD

  1.00 program credit

  • 

    

    Diana V. Do, MD

  • 

    

    David Boyer, MD

  1.00 program credit

• 

  MinuteCE®

  Lighting the Way: Exploring the Potential of Photobiomodulation for Dry AMD Treatment

  Janis T. Eells, Ph.D.; David Boyer, MD

  1.00 credit 8 episodes

  • 

    

    Janis T. Eells, Ph.D.

  • 

    

    David Boyer, MD

  • 

    

    Diana V. Do, MD

  • 

    

    Marion Munk, MD, Ph.D

  1.00 credit 8 episodes

• 

  RestartResume

  Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma

  RestartResume

  Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma

  MinuteCE®

  Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma

  Janis T. Eells, Ph.D.

  1.00 program credit

  • 

    

    Janis T. Eells, Ph.D.

  1.00 program credit

• 

  RestartResume

  Patient-Centered Care and Integration of Photobiomodulation Therapy into Clinical Practice

  RestartResume

  Patient-Centered Care and Integration of Photobiomodulation Therapy into Clinical Practice

  MinuteCE®

  Patient-Centered Care and Integration of Photobiomodulation Therapy into Clinical Practice

  Diana V. Do, MD; Marion Munk, MD, Ph.D

  1.00 program credit

  • 

    

    Diana V. Do, MD

  • 

    

    Marion Munk, MD, Ph.D

  1.00 program credit

• 

  RestartResume

  Real-World Evidence of Photobiomodulation Efficacy in Ocular Indications

  RestartResume

  Real-World Evidence of Photobiomodulation Efficacy in Ocular Indications

  MinuteCE®

  Real-World Evidence of Photobiomodulation Efficacy in Ocular Indications

  Marion Munk, MD, Ph.D; David Boyer, MD

  1.00 program credit

  • 

    

    Marion Munk, MD, Ph.D

  • 

    

    David Boyer, MD

  1.00 program credit

• 

  RestartResume

  Integration of Photobiomodulation Therapy into the Age-Related Macular Degeneration Treatment Landscape

  RestartResume

  Integration of Photobiomodulation Therapy into the Age-Related Macular Degeneration Treatment Landscape

  MinuteCE®

  Integration of Photobiomodulation Therapy into the Age-Related Macular Degeneration Treatment Landscape

  David Boyer, MD; Marion Munk, MD, Ph.D

  1.00 program credit

  • 

    

    David Boyer, MD

  • 

    

    Marion Munk, MD, Ph.D

  1.00 program credit